Showing 1 - 5 of 5 trials

• Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration

  Stanford is currently not accepting patients for this trial.

• Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy

  Stanford is currently not accepting patients for this trial.

• Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

  Stanford is currently not accepting patients for this trial.

• Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration

  Stanford is currently not accepting patients for this trial.

• A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  Stanford is currently accepting patients for this trial.

Showing 1 - 5 of 5 trials

• Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)

  Stanford is currently accepting patients for this trial.

• Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

  Stanford is currently accepting patients for this trial.

• Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD

  Stanford is currently not accepting patients for this trial.

• Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

  Stanford is currently accepting patients for this trial.

• Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD

  Stanford is currently accepting patients for this trial.